blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0599968

EP0599968 - OXAZOLIDINONE DERIVATIVES USEFUL AS ANTIARRHYTHMIC AND ANTIFIBRILLATORY AGENTS [Right-click to bookmark this link]
Former [1994/23]CYCLIC URETHANES USEFUL AS ANTIARRHYTHMIC AND ANTIFIBRILLATORY AGENTS
[1998/32]
StatusNo opposition filed within time limit
Status updated on  10.11.2000
Database last updated on 11.11.2024
Most recent event   Tooltip10.11.2000No opposition filed within time limitpublished on 27.12.2000 [2000/52]
Applicant(s)For all designated states
PROCTER & GAMBLE PHARMACEUTICALS, INC.
17 Eaton Avenue
Norwich, NY 13815 / US
[1999/34]
Former [1994/23]For all designated states
PROCTER & GAMBLE PHARMACEUTICALS
17 Eaton Avenue
Norwich, NY 13815 / US
Inventor(s)01 / PELOSI, Stanford, Salvatore, Jr.
111 Hillview Court
Norwich, NY 13815 / US
02 / YU, Chia-Nien
24 Hillview Drive
Norwich, NY 13815 / US
[1994/23]
Representative(s)Bérogin, Francis, et al
Cabinet Plasseraud
ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR
Paris / FR
[N/P]
Former [2000/26]Bérogin, Francis, et al
Cabinet Plasseraud 84, rue d'Amsterdam
75440 Paris Cedex 09 / FR
Former [1999/34]Woof, Victoria, et al
Patent Dept., Procter & Gamble Technical Centres Limited, Rusham Park, Whitehall Lane
Egham TW20 9NW / GB
Former [1994/23]Engisch, Gautier, et al
Procter & Gamble European Technical Center N.V. Temselaan 100
B-1853 Strombeek-Bever / BE
Application number, filing date92918216.010.08.1992
[1994/23]
WO1992US06682
Priority number, dateUS1991074486514.08.1991         Original published format: US 744865
[1994/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9304064
Date:04.03.1993
Language:EN
[1993/06]
Type: A1 Application with search report 
No.:EP0599968
Date:08.06.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.1993 takes the place of the publication of the European patent application.
[1994/23]
Type: B1 Patent specification 
No.:EP0599968
Date:12.01.2000
Language:EN
[2000/02]
Search report(s)International search report - published on:EP04.03.1993
ClassificationIPC:C07D413/12, A61K31/42, C07D413/14, A61K31/34, A61K31/41
[1994/23]
CPC:
C07D413/10 (EP,US); A61P9/06 (EP); C07D413/12 (EP,US);
C07D413/14 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   SE [1994/23]
TitleGerman:OXAZOLIDINON-DERIVATE MIT ANTIARRHYTHMISCHER UND ANTIFIBRILLATORISCHE WIRKUNG[1998/32]
English:OXAZOLIDINONE DERIVATIVES USEFUL AS ANTIARRHYTHMIC AND ANTIFIBRILLATORY AGENTS[1998/32]
French:DERIVES D'OXAZOLIDINONE UTILISES COMME AGENTS ANTIARYTHMIQUES ET ANTIFIBRILLANTS[1998/32]
Former [1994/23]ZYKLISCHE URETHANE MIT ANTIARRHYTHMISCHER UND ANTIFIBRILLATORISCHE WIRKUNG
Former [1994/23]CYCLIC URETHANES USEFUL AS ANTIARRHYTHMIC AND ANTIFIBRILLATORY AGENTS
Former [1994/23]NOUVELLES UREES CYCLIQUES UTILISEES COMME AGENTS ANTIARYTHMIQUES ET ANTIFIBRILLANTS
Entry into regional phase19.01.1994National basic fee paid 
19.01.1994Designation fee(s) paid 
19.01.1994Examination fee paid 
Examination procedure24.02.1993Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.01.1994Examination requested  [1994/23]
06.03.1997Despatch of a communication from the examining division (Time limit: M06)
16.10.1997Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.12.1997Reply to a communication from the examining division
26.02.1998Despatch of a communication from the examining division (Time limit: M04)
12.06.1998Reply to a communication from the examining division
14.10.1998Despatch of communication of intention to grant (Approval: Yes)
13.07.1999Communication of intention to grant the patent
06.10.1999Fee for grant paid
06.10.1999Fee for publishing/printing paid
Divisional application(s)EP99107448.5  / EP0957103
EP99108059.9
Opposition(s)13.10.2000No opposition filed within time limit [2000/52]
Request for further processing for:23.12.1997Request for further processing filed
23.12.1997Full payment received (date of receipt of payment)
Request granted
19.01.1998Decision despatched
Fees paidRenewal fee
19.01.1994Renewal fee patent year 03
09.08.1995Renewal fee patent year 04
10.08.1996Renewal fee patent year 05
08.08.1997Renewal fee patent year 06
12.08.1998Renewal fee patent year 07
04.08.1999Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]NL285000  ;
 [A]GB843834  (NORWICH PHARMA CO);
 [A]FR385M  (NORWICH PHARMA CO [US]);
 [A]GB865796  (PFIZER & CO C);
 [A]FR1274399  (NORWICH PHARMA CO);
 [A]FR1284523  (NORWICH PHARMA CO);
 [A]GB995475  (NORWICH PHARMA CO);
 [A]CH398599  (OM LAB SA [CH]);
 [A]US3288787  (GIANGIACOMO MASSAROLI);
 [A]FR1590053  ;
 [A]US4393204  (PELOSI JR STANFORD S);
 [A]FR2599741  (ABIC LTD [IL])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.